DISCOUNT-OPTIONSSCHEIN - FRESENIUS MEDICAL CARE Stock

Certificat

DE000HD0UR41

Real-time BOERSE MUENCHEN 09:47:06 2024-06-04 EDT
1.76 EUR +1.15% Intraday chart for DISCOUNT-OPTIONSSCHEIN - FRESENIUS MEDICAL CARE
Current month+3.57%
1 month+1.75%
Date Price Change
24-06-04 1.76 +1.15%
24-06-03 1.74 +3.57%
24-05-31 1.68 +2.44%
24-05-30 1.64 +5.13%
24-05-29 1.56 -9.83%

Real-time BOERSE MUENCHEN

Last update June 04, 2024 at 09:47 am

More quotes

Static data

Product typeExotic Products
Buy / SellCALL
Underlying FRESENIUS MEDICAL CARE AG
IssuerLogo Issuer UniCredit UniCredit
WKN HD0UR4
ISINDE000HD0UR41
Date issued 2023-11-21
Strike 40
Maturity 2024-09-18 (106 Days)
Parity 1 : 1
Emission price 1.46
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 2.31
Lowest since issue 0.75
Spread 0.03
Spread %1.73%

Company Profile

Fresenius Medical Care AG, formerly Fresenius Medical Care AG & Co. KGaA is a Germany-based Company, which is a kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company also develops and manufactures a wide variety of health care products, which includes dialysis and non-dialysis products. Its dialysis products include hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. The Company supplies dialysis clinics it owns, operates or manages with a broad range of products, and sells dialysis products to other dialysis service providers.
Sector
-
More about the company

Ratings for Fresenius Medical Care AG

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Fresenius Medical Care AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
39.25 EUR
Average target price
39.97 EUR
Spread / Average Target
+1.84%
Consensus